Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 3
2004 1
2005 3
2006 3
2007 8
2008 4
2009 5
2010 3
2011 4
2012 4
2013 4
2014 3
2015 1
2016 4
2017 3
2018 8
2019 9
2020 10
2021 9
2022 5
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Cerulean Cataract.
Provencher LM, Critser B, Johnson AT. Provencher LM, et al. Among authors: johnson at. JAMA Ophthalmol. 2018 Dec 1;136(12):e183150. doi: 10.1001/jamaophthalmol.2018.3150. Epub 2018 Dec 13. JAMA Ophthalmol. 2018. PMID: 30543353 No abstract available.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Metamorphism and the evolution of plate tectonics.
Holder RM, Viete DR, Brown M, Johnson TE. Holder RM, et al. Among authors: johnson te. Nature. 2019 Aug;572(7769):378-381. doi: 10.1038/s41586-019-1462-2. Epub 2019 Aug 7. Nature. 2019. PMID: 31391583
Cataracts and corticosteroids in granulocyte donors.
Strauss RG, Johnson AT. Strauss RG, et al. Among authors: johnson at. Transfusion. 2011 May;51(5):904-7. doi: 10.1111/j.1537-2995.2011.03068.x. Transfusion. 2011. PMID: 21545589 No abstract available.
Giant impacts and the origin and evolution of continents.
Johnson TE, Kirkland CL, Lu Y, Smithies RH, Brown M, Hartnady MIH. Johnson TE, et al. Nature. 2022 Aug;608(7922):330-335. doi: 10.1038/s41586-022-04956-y. Epub 2022 Aug 10. Nature. 2022. PMID: 35948713
Managerial and Organizational Challenges in the Age of AI.
Obradovich N, Johnson T, Paulus MP. Obradovich N, et al. Among authors: johnson t. JAMA Psychiatry. 2024 Mar 1;81(3):219-220. doi: 10.1001/jamapsychiatry.2023.5247. JAMA Psychiatry. 2024. PMID: 38265819
91 results